Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Hepatectomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 36 Liver Neoplasms 12 Colorectal Neoplasms 8 Cholangiocarcinoma 5 Recurrence 4 Neoplasm Metastasis 4 Pancreatic Neoplasms 3 Colonic Neoplasms 3 Rupture, Spontaneous 2 Postoperative Complications 2 Stomach Neoplasms 1 Sarcopenia 1 Reperfusion Injury 1 Obesity, Morbid 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Metabolic Syndrome 1 Liver Surgery 1 Klatskin Tumor 1 Ischemia 1 Hypertension, Portal 1 Hemangioma 1 Focal Nodular Hyperplasia 1 Fibrosis 1 Disease Progression 1 Conversion Disorder 1 Colorectal Cancer Metastatic 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma 1 Abdominal Injuries 1

Interventions

Oxaliplatin 252 Capecitabine 175 Fluorouracil 162 Cisplatin 139 Docetaxel 120 S 1 (combination) 115 Leucovorin 108 Paclitaxel 107 Irinotecan 97 pembrolizumab 80 Trastuzumab 57 apatinib 54 Nivolumab 47 Drug Therapy 46 Surgical Procedures, Operative 38 sintilimab 36 Radiotherapy 36 Ramucirumab 34 Bevacizumab 34 tislelizumab 29 Hyperthermic Intraperitoneal Chemotherapy 29 Epirubicin 29 titanium silicide 26 Carboplatin 26 XELOX 24 Gastrectomy 24 Cyclophosphamide 24 Folfox protocol 20 Tegafur 19 Cetuximab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04574245 2022-10-05

RECORD

Chinese PLA General Hospital

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡